Oral versus parenteral administration of methotrexate for the treatment of active RA [0.03%]
口服给药与静脉或皮下注射给药治疗活动性类风湿关节炎甲氨蝶呤的疗效及安全性的比较
Derrick J Todd,Michael E Weinblatt
Derrick J Todd
Claas Hinze,Hermine I Brunner
Claas Hinze
Balancing efficacy and cancer risk of cyclophosphamide for patients with Wegener's granulomatosis [0.03%]
评估韦格纳肉芽肿病患者环磷酰胺疗效和致癌风险的平衡关系
Eamonn S Molloy,Carol A Langford
Eamonn S Molloy
Haralampos M Moutsopoulos,George E Fragoulis
Haralampos M Moutsopoulos
In a multicenter, open-label study conducted in Japan between July 2004 and May 2005, Nakayamada et al. tested the safety and efficacy of mizoribine for the treatment of primary Sjögren's syndrome (pSS). Mizoribine 50 mg was administered t...
Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases [0.03%]
抗肿瘤坏死因子疗法在血管炎治疗中的作用：综述文章
Carol A Langford
Carol A Langford
The introduction of targeted biologic agents directed against tumor necrosis factor (TNF) has represented a novel and exciting avenue for investigation into therapies for the vasculitic diseases. In vasculitic diseases that are associated w...
Is computer-assisted management necessary for patients with early rheumatoid arthritis? [0.03%]
计算机辅助管理早期类风湿性关节炎患者有必要吗？
Daniel Aletaha,Josef Smolen
Daniel Aletaha
Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus [0.03%]
系统性红斑狼疮女性患者的视神经炎和复发性脊髓炎
Julius Birnbaum,Douglas Kerr
Julius Birnbaum
Background: A 38-year-old woman with systemic lupus erythematosus presented with headaches and bilateral hearing loss. Brain MRI was initially suggestive of small-vessel disease developing in the context of neuropsychiatr...
Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis? [0.03%]
早期使用柳氮磺胺吡啶治疗幼年特发性关节炎的效果如何？
Tracy V Ting,Daniel J Lovell
Tracy V Ting
Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus [0.03%]
Th17型辅助性T细胞可能是系统性红斑狼疮的治疗新靶点
Hai Feng Pan,Dong Qing Ye,Xiang Pei Li
Hai Feng Pan